We are live on ! Find out more
LBPH

Longboard Pharmaceuticals, Inc. Common Stock
LBPH

Delisted

LBPH was delisted on the 29th of November, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Longboard Pharmaceuticals, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 124 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 125 → 0 (-125)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $1.33B → $0 (-$1.33B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 124

Holders
–
Holders Change
-125
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
124
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$145M
2
FCM
Farallon Capital Management
California
-$105M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$97M
4
BlackRock
BlackRock
New York
-$94.6M
5
CAM
Cormorant Asset Management
Massachusetts
-$93M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
– -$145M -4,350,099 Closed
FCM
2
Farallon Capital Management
California
– -$105M -3,150,857 Closed
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
– -$97M -2,909,257 Closed
BlackRock
4
BlackRock
New York
– -$94.6M -2,837,880 Closed
CAM
5
Cormorant Asset Management
Massachusetts
– -$93M -2,790,462 Closed
Vanguard Group
6
Vanguard Group
Pennsylvania
– -$67.8M -2,033,068 Closed
Viking Global Investors
7
Viking Global Investors
Connecticut
– -$65.6M -1,969,041 Closed
Wellington Management Group
8
Wellington Management Group
Massachusetts
– -$53M -1,590,072 Closed
PCH
9
Polar Capital Holdings
United Kingdom
– -$36.8M -1,102,740 Closed
IHAM
10
Integral Health Asset Management
New York
– -$35M -1,050,000 Closed
Goldman Sachs
11
Goldman Sachs
New York
– -$34.2M -1,026,703 Closed
WP
12
Woodline Partners
California
– -$33.5M -1,004,705 Closed
Pictet Asset Management
13
Pictet Asset Management
Switzerland
– -$30.6M -918,573 Closed
Jennison Associates
14
Jennison Associates
New York
– -$30.6M -917,528 Closed
SL
15
Siren LLC
Connecticut
– -$30.1M -903,227 Closed
State Street
16
State Street
Massachusetts
– -$28.5M -855,814 Closed
Geode Capital Management
17
Geode Capital Management
Massachusetts
– -$24.9M -746,147 Closed
DCM
18
Driehaus Capital Management
Illinois
– -$24.3M -729,549 Closed
EA
19
Emerald Advisers
Pennsylvania
– -$22.8M -683,642 Closed
Lord, Abbett & Co
20
Lord, Abbett & Co
New Jersey
– -$20.9M -626,905 Closed
American Century Companies
21
American Century Companies
Missouri
– -$19M -569,738 Closed
Marshall Wace
22
Marshall Wace
United Kingdom
– -$16.9M -507,781 Closed
PHP
23
Parkman Healthcare Partners
Connecticut
– -$16.4M -491,272 Closed
EMFAT
24
Emerald Mutual Fund Advisers Trust
Pennsylvania
– -$14M -419,462 Closed
Morgan Stanley
25
Morgan Stanley
New York
– -$12.5M -375,256 Closed
1
2 3 4 5

LBPH Hedge Fund Activity: Q4 2024 in Review

0 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Longboard Pharmaceuticals, Inc. Common Stock (LBPH) for Q4 2024, worth a combined $0 — down 100% from $1.33B a quarter earlier.

Sellers outnumbered buyers: 124 funds closed out of LBPH and 0 opened new positions — a net loss of 124 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $145M sold.

  • 0 institutional investors held Longboard Pharmaceuticals, Inc. Common Stock (LBPH) as of Q4 2024, down from 125 in Q3 2024.
  • Funds reported $0 of Longboard Pharmaceuticals, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Longboard Pharmaceuticals, Inc. Common Stock positions in Q4 2024 and 124 closed out, a net change of -124 holders.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock seller in Q4 2024 was Fidelity Investments, an estimated $145M sold.

Based on aggregated 13F filings for Q4 2024.